SCHEMBL3607692

SCHEMBL3607692

O=C(Nc1nnc(C(F)(F)F)s1)c1ccc(CN(Cc2cccs2)C(=O)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
NPC1 O15118 7/20 0.51
RAB9A P51151 6/20 0.51
HTT P42858 5/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
TP53 P04637 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
MAPT P10636 1/20 0.51
ATM Q13315 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.48
TAS1R3 Q7RTX0 1/20 0.47
TAS1R1 Q7RTX1 1/20 0.47
TAS1R2 Q8TE23 1/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
POLB P06746 3/20 0.46
LMNA P02545 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3602101 0.83 NPC1 (0.50) NPC1RAB9AHTTSMN1; SMN2TP53
SCHEMBL3611655 0.79 NPC1 (0.50) NPC1RAB9AHTTSMN1; SMN2TP53
SCHEMBL13316895 0.78 NPC1 (0.51) HDAC1NPC1RAB9AHTTSMN1; SMN2
SCHEMBL3609613 0.78 HDAC6 (0.55) HDAC1HDAC6NPC1RAB9AHTT
SCHEMBL3612223 0.76 HDAC6 (0.83) HDAC1HDAC6POLBTDP1
SCHEMBL3601387 0.75 NPC1 (0.57) HDAC1HDAC6NPC1RAB9AHTT
SCHEMBL3601082 0.75 HDAC6 (0.66) HDAC1HDAC6NPC1RAB9AHTT
SCHEMBL3612348 0.73 PDE5A (0.64) HDAC1HDAC6SMN1; SMN2KDM4E
SCHEMBL3610541 0.73 HDAC1 (0.63) HDAC1HDAC6
SCHEMBL3612530 0.72 HDAC6 (0.62) HDAC1HDAC6NPC1RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152188-A1 Novel Heterocyclic Compounds ORCHID RESEARCH LABORATORIES LIMITED (IN) 2010-06-17 US claimed
US-20100152188-A1 Novel Heterocyclic Compounds ORCHID RESEARCH LABORATORIES LIMITED (IN) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152188-A1 Novel Heterocyclic Compounds CYP11B2, CYP3A5, CYP11B1 HDAC1 307/4885HDAC6 90/4885NPC1 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.